The prevalence of venous diseases is rising as lifestyle changes make obesity and venous diseases more prevalent for treatments in the venous diseases treatment market.Wilmington, Delaware, United States, July 18, 2023 (GLOBE NEWSWIRE) The global venous diseases treatment market is expected to be valued at US$ 5.9 billion in 2021. By 2031, there is expected to be revenues of US$ 11.3 billion in the market, reflecting a growth of 6.8% CAGR from 2022 to 2031. According to a new position stateme
By Josh Beckerman Shares of cancer-focused Xenetic Biosciences were down 15% to $3.56 Wednesday following a presentation during the Virtual Investor Summer.
enVVeno Medical Provides Enrollment Update for Ongoing VenoValve(R) U S Pivotal Study and Announces Upcoming Investor and KOL Events bostonstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bostonstar.com Daily Mail and Mail on Sunday newspapers.
enVVeno Medical Provides Enrollment Update for Ongoing VenoValve(R) U S Pivotal Study and Announces Upcoming Investor and KOL Events dallassun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallassun.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced that Saundra Pelletier, Chief Executive Officer, and Amy Raskopf,.